Stephan Grupp

31PUBLICATIONS
221CO-AUTHORS
Child and adolescent developmentMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 29, 2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

|Sep 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer.

Anna Maria Giudice, Stephanie Matlaga, Sydney L Roth

|Aug 25, 2025
Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells.

Tomasz M Grzywa, Alexandra Neeser, Ranjani Ramasubramanian

|Apr 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.

Pablo Domizi, Jolanda Sarno, Astraea Jager

|Jan 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall

|Dec 27, 2024
CD4+ T Cells Mediate Dendritic Cell Licensing to Promote Multi-Antigen Anti-Leukemic Immune Response.

Luis Gil-de-Gómez, Joseph J Mattei, Jessica H Lee

Pageof 6

Frequent Collaborators

8 joint publications

Regina M Myers

7 joint publications

Carl H June

7 joint publications

Shannon L Maude

6 joint publications

Yimei Li